Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
McKesson
Covington
McKinsey
Queensland Health

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 9,388,235

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,388,235
Title:Methods and compositions for the treatment of antibody mediated neuropathies
Abstract: The use of a therapeutic capable of inhibiting complement, e.g., an anti-C5 antibody, to treat antibody mediated neuropathies is disclosed.
Inventor(s): Halstead; Susan (Glasgow, GB), Willison; Hugh (Glasgow, GB), Rother; Russell P. (Oklahoma City, OK)
Assignee: Alexion Pharmaceuticals, Inc. (New Haven, CT)
Application Number:12/439,070
Patent Claims:see list of patent claims

Details for Patent 9,388,235

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Alexion Pharmaceuticals, Inc. (New Haven, CT) 2026-09-05 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Fuji
US Army
Fish and Richardson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.